Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Enterprise Value: 1.446B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 1.446B |
| November 14, 2024 | 1.402B |
| November 13, 2024 | 1.485B |
| November 12, 2024 | 1.385B |
| November 11, 2024 | 1.211B |
| November 08, 2024 | 1.487B |
| November 07, 2024 | 1.629B |
| November 06, 2024 | 1.521B |
| November 05, 2024 | 2.363B |
| November 04, 2024 | 2.562B |
| November 01, 2024 | 2.482B |
| October 31, 2024 | 2.335B |
| October 30, 2024 | 2.350B |
| October 29, 2024 | 2.334B |
| October 28, 2024 | 2.628B |
| October 25, 2024 | 2.682B |
| October 24, 2024 | 2.642B |
| October 23, 2024 | 2.732B |
| October 22, 2024 | 2.675B |
| October 21, 2024 | 2.500B |
| October 18, 2024 | 2.520B |
| October 17, 2024 | 2.495B |
| October 16, 2024 | 2.435B |
| October 15, 2024 | 2.416B |
| October 14, 2024 | 2.438B |
| Date | Value |
|---|---|
| October 11, 2024 | 2.377B |
| October 10, 2024 | 2.372B |
| October 09, 2024 | 2.382B |
| October 08, 2024 | 2.380B |
| October 07, 2024 | 2.363B |
| October 04, 2024 | 2.457B |
| October 03, 2024 | 2.447B |
| October 02, 2024 | 2.412B |
| October 01, 2024 | 2.429B |
| September 30, 2024 | 2.467B |
| September 27, 2024 | 2.342B |
| September 26, 2024 | 2.370B |
| September 25, 2024 | 2.363B |
| September 24, 2024 | 2.366B |
| September 23, 2024 | 2.284B |
| September 20, 2024 | 2.190B |
| September 19, 2024 | 2.232B |
| September 18, 2024 | 2.215B |
| September 17, 2024 | 2.228B |
| September 16, 2024 | 2.243B |
| September 13, 2024 | 2.196B |
| September 12, 2024 | 2.192B |
| September 11, 2024 | 2.158B |
| September 10, 2024 | 2.177B |
| September 09, 2024 | 2.215B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
589.17M
Minimum
Mar 18 2020
6.300B
Maximum
Mar 16 2021
2.529B
Average
2.284B
Median
Sep 23 2024
Enterprise Value Benchmarks
| Bruker Corp | 9.962B |
| Karyopharm Therapeutics Inc | 159.07M |
| Apellis Pharmaceuticals Inc | 3.323B |
| cbdMD Inc | 0.8319M |
| Flora Growth Corp | 12.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.21M |
| Revenue (Quarterly) | 284.28M |
| Total Expenses (Quarterly) | 287.96M |
| EPS Diluted (Quarterly) | -0.33 |
| Gross Profit Margin (Quarterly) | 60.95% |
| Profit Margin (Quarterly) | -21.18% |
| Earnings Yield | -10.74% |
| Operating Earnings Yield | 9.49% |
| Normalized Earnings Yield | -10.50 |